维普中文期刊产品整合服务
34篇 您的检索式:作者名="Vistica"
    题名 作者 年代 出处 被引量
1Potent ation of melphalan cytotoxicity in human ovarian cancer cell lines by GSH depletion显示文摘GREEN JA VISTICA DT YOUNG RC 1984Cancer Res1984,44,:1
2Gene expres-sion profiling of alveolar soft - part sarcoma ( ASPS) 显示文摘Stockwin LH Vistica DT Kenney S 2009BMC Cancer2009,9,:1
3Tetrazolium-based assays for cellular viability:a critical examination of selected parameters affecting formazan production显示文摘VISTICA D T SKEHAN P SCUDIERO D 1991Cancer Research1991,51,10:1
4T cell tolerance to a neo-self antigen expressed by thymic epithelial cells: the soluble form is more effective than the membrane-bound form 显示文摘Zhang M Vacchio MS Vistica BP 2003J Immunol2003,170,8:1
5Reduction in cellular glutathione by buthionine sulfoximine and sensitization of murine tumer cells resistant to L-phenylalanine mustard 显示文摘 Suzukake K Vistica BP 1984Biochem Pharmacol1984,33,3:1
6SLAT/Def6 plays a critical role in the pathogenic process of experimental autoimmune unveitis (EAU)显示文摘Vistica BP Shi G Nuqent L 0,,:1
7Phenotypes of Th lineages generated by the commonly used activation with anti-CD3/CD28 antibodies differ from those generated by the physiological activation with the specific antigen显示文摘T 助手(Th ) 系被在极化期间与 anti-CD3/CD28 抗体激活 CD4 房间在 vitro 产生了。然而,生理地, Th 系的产生被介绍抗原的房间(APC ) 被有特定的抗原的激活介绍。这里,我们使用了 T 房间受体(TCR ) 当在二个激活模式中的任何一个一个产生了时,比较 Th1, Th9 和 Th17 系的显型的转基因的老鼠。对母鸡鸡蛋溶解酵素(司死亡及冥府的女神) 特定的系 Th 房间,采纳地被变成转基因地在他们的透镜表示司死亡及冥府的女神的接受者老鼠。显著差别在 Th1, Th9 或 Th17 的系之间被发现,在他们的能力在二个模式中的任何一个一个产生了移居到并且在接受者怒气并且,重要地增殖在接受者老鼠眼睛导致发炎。实质的差别也在他们某些 chemokines 和 chemokine 受体的抄本表示侧面在系对之间被观察。然而,令人惊讶地,靠近的类似在三显型的系的抄本表示侧面之间被观察,由一样的模式激活。而且,二个激活模式产生的 Th 房间系在他们基因表示的模式更加不同,由 microarray 分析监视了,但是与一样的激活模式产生的另外的显型的系展出了公共。这研究因此证明激活与 anti-CD3/CD28 抗体产生的(i) Th 系不同于 antigen/APC 产生的系;并且(ii ) 激活的模式决定主要抄本的表示侧面到大程度。Cuiyan Tan Lai Wei Barbara P Vistica Guangpu Shi Eric F Wawrousek Igal Gery 2014Cellular & Molecular Immunology2014,11,3:1
8Tetrazolium-based assay for cellular viability:A critical examination of selected parameters affecting formazan production显示文摘 Skehan P Scudiero D 1991Cancer Res1991,51,:1
9Tetrazolium based assay for cellular viability: A critical exacnination of selected parameters affecting formazan production显示文摘Vistica DT Skenhan P Seudiero D 1991Cancer Res1991,51,:1
10Gene expression profiling of alveolar soft-part sarcoma (ASPS)显示文摘Stockwin LH Vistica DT Kenney S 2009BMC Cancer2009,15,9:1
11Induction of ocular inflammation by T-helper lymphocytes type 2显示文摘Kim SJ Zhang M Vistica BP 2002Invest Ophthalmol Vis Sci2002,43,3:1
12SLAT/Def6 plays a critical role in the pathogenic process of experimental autoimmune unveitis(EAU)显示文摘Vistica BP Shi G Nuqent L 0,,:1
13Gene expression profiling of alveolar soft-part sarcoma(ASPS)显示文摘STOCKWIN LH VISTICA DT KENNEY S 2009BMC Cancer2009,9,:1
14New colorimetrie eytotoxicity assay for anticancer-drug screening显示文摘Skehan P Storeng R Scudiero D Monks A McMahon J Vistica D 1990J Natl Cancer Inst1990,82,:1
15l Tetrazolium-based as says for cellular viability: a critical examination of selected parameters affecting formazan production 显示文摘Vistica DT Skenhan D Seudiero D et a 1991Cancer Res1991,51,10:1
16Induced regulatory T-cells (iTregs) generated by activation with anti-CD3/CD28 antibodies differ from those generated by the physiological-like activation with antigen/APC显示文摘Zhao C Shi G Vistica B P 2014Cell Immunol2014,290,2:1
17Tetrazolium-based assays for cellular viability: a critical examization of selected parameters affecting formazan production 显示文摘Vistica DT Skehan P Scudiero D 1991Cancer Res1991,51,:1
18Immunohistochemical discrimination between the ASPL-TFE3 fusion proteins of alveolar sott part sarcoma显示文摘Vistica DT Krosky PM Kenney S 2008J Pediatr Hematol Oncol2008,30,:1
19Unlike Th1,Th17 cells mediate sustained autoimmune inflammation and are highly resistant to restimulation-induced cell death显示文摘Shi G Ramaswamy M Vistica BP 2009J Immunol2009,183,11:1
20Gene expression profiling of alveolar soft-part sarcoma(ASPS)显示文摘Stockwin LH Vistica DT Kenney S 2009BMC Cancer2009,9,:1
返回顶部 每页显示:
共2页 首页 上一页 第1页 下一页 末页 /2 跳转

网站首页 | 关于我们 | 联系我们 | 产品服务 | 客服中心 | 广告服务 | 版权声明 | 网站联盟 | 友情链接 | 售卡网点

版权所有© 渝B2-20050021-1 渝公网安备 50019002500403号 违法和不良信息举报中心

互联网出版许可证 新出网证(渝)字10号 全国400电话 - 免长途话费